Sam Backenroth
2017 - Ohr Pharmaceutical
In 2017, Sam Backenroth earned a total compensation of $216.7K as Chief Financial Officer at Ohr Pharmaceutical, a 76% decrease compared to previous year.
Compensation breakdown
| Salary | $200,000 |
|---|---|
| Other | $16,729 |
| Total | $216,729 |
Backenroth received $200K in salary, accounting for 92% of the total pay in 2017.
Backenroth also received $16.7K in other compensation.
Rankings
In 2017, Sam Backenroth's compensation ranked 13,928th out of 14,666 executives tracked by ExecPay. In other words, Backenroth earned more than 5.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,928 out of 14,666 | 5th |
Division Manufacturing | 5,466 out of 5,772 | 5th |
Major group Chemicals And Allied Products | 1,963 out of 2,075 | 5th |
Industry group Drugs | 1,636 out of 1,731 | 6th |
Industry Pharmaceutical Preparations | 1,254 out of 1,333 | 6th |
Source: SEC filing on September 7, 2018.
Backenroth's colleagues
We found two more compensation records of executives who worked with Sam Backenroth at Ohr Pharmaceutical in 2017.